Dear Sirs,

A 52-year-old Hispanic man was admitted to hospital with a history of seizures, right sided hemiparesis, and new onset of aphasia. He complained of seizures that began 3 years prior which were characterized by 5 min episodes of right leg twitching, spreading to his right arm. The patient had no known risk factors for seizures, and the addition of topiramate had reduced his seizure frequency to about once every 2--3 days. A previous MRI of his brain showed nonspecific fluid attenuation inversion recovery (FLAIR) hyperintensities in the left cerebral hemisphere; however, his EEG was normal. In the past, the patient had a brain biopsy for a workup of the FLAIR hyperintensities in the left hemisphere, which was inconclusive due to inadequate tissue sampling. His neurological examination was remarkable for a global aphasia, 4/5 strength on the right upper and lower extremities, and a right sided spastic gait with right sided internal circumduction of the foot.

MRI scan of the brain showed extensive fluid attenuation inversion recovery (FLAIR) hyperintensities restricted to the left cerebral hemisphere, with multiple foci of nodular and ring enhancement, along with involvement of the left calvarium (Fig. [1](#Fig1){ref-type="fig"}a--c). Serum rheumatologic and infectious studies were negative outside of a positive serum *Bartonella* antibody titer. Cerebrospinal fluid results were unremarkable. Since the patient had a history of working with farm animals, he was treated empirically with doxycycline for 4 weeks, but with no noticeable improvement. MRI scans of the brain over the next few months showed progression of the FLAIR hyperintensities in the left hemisphere. Since the patient was a recent immigrant from Mexico, he was also treated with RIPE (rifampin, isoniazid, pyrazinamide and ethambutol) therapy for presumed tuberculosis with no noticeable improvement.Fig. 1MRI brain revealing extensive fluid attenuated inversion recovery (FLAIR) lesions restricted to the left cerebral hemisphere **(a)**, with multiple foci of nodular and ring enhancement **(b)**, along with involvement of the left calvarium **(c)**. After treatment with glucocorticoids and cyclophosphamide, the repeated MRI showed resolution of most of the FLAIR hyperintensities in the left cerebral hemisphere **(d)**, and resolution of most of the enhancing areas on T1 post contrast imaging **(e)**, along with interval aneurysm clipping of the left anterior cerebral artery aneurysm and left middle cerebral artery aneurysm

After a month, the patient presented to another hospital because of worsening aphasia and headaches. An MRI scan showed further progression of the left hemispheric lesions. Four-vessel cerebral angiogram was notable for a small left middle cerebral artery saccular aneurysm and a right pericallosal anterior cerebral artery aneurysm, which were both surgically clipped, but no beading or stensoses were visualized. He then had a left frontal stereotactic brain biopsy performed revealing dense perivascular chronic inflammation with mixed T and B lymphocytes, along with reactive astrocytosis in surrounding brain. The inflammatory infiltrates were sharply demarcated from the surrounding brain and did not extend into the surrounding neuroglial tissue. The findings were consistent with primary angiitis of the CNS (PACNS) (Fig. [2](#Fig2){ref-type="fig"}a--f). The patient returned to our care and was treated with corticosteroids and cyclophosphamide. Within days after initial treatment the patient noticed improvement of speech and strength.Fig. 2H&E stained section of a vessel, cut in longitudinal section, shows polymorphous transmural inflammatory infiltrate between the *arrows* **(a)**. Note effacement of normal vessel wall by the inflammatory infiltrate **(b)**. Sections of the biopsy immunostained with a marker for T cells (CD3) and B cells (CD20), indicating that the transmural infiltrate is composed predominantly of T lymphocytes, with a significant admixture of B lymphocytes (**c**--**f**)

At a follow up visit 3 months later, the patient reported near complete resolution of his aphasia, seizures and right sided hemiparesis. He has not had a seizure in over 6 months, and a follow up MRI brain revealed significant improvement of the FLAIR and significantly decreased areas of enhancement in the left hemisphere (Fig. [1](#Fig1){ref-type="fig"}d, e).

Our case is the first in the literature that reports a slowly progressive, single hemispheric involvement of PACNS. The patient's focal, unilateral lesion on MRI and slow indolent course initially raised the question of infection, tumor, or even a progressive demyelinating disease. In addition, the unusual manifestation of focal involvement of the overlying calvarium raised the possibility of granulomatous disease, such as vasculitis occurring in the setting of tuberculous meningitis. However, the diagnostic studies for tuberculosis including tuberculin skin test, sputum cultures, and cerebrospinal fluid cultures were all negative, and the MRI did not reveal the basilar meningeal thickening that might suggest tuberculous meningitis.

Our patient required two brain biopsies before there was adequate sampling of the tissue and vessels involved to make the diagnosis, which is often the case in PACNS \[[@CR1]--[@CR3]\]. He also had a four vessel cerebral angiogram which revealed anterior cerebral and middle cerebral artery aneurysms, which have been described in the literature in association with PACNS \[[@CR4]\].

This represents the first case report of focal PACNS. Glucocorticoid and immunosuppressive therapy are first-line treatments for PACNS based on extrapolations from treatment of other systemic vasculitides and from expert consensus groups, although intravenous immunoglobulin, plasmapharesis, and mycophenolate mofetil have also shown some success \[[@CR5]--[@CR7]\]. Our case describes an unusual presentation of PACNS which had an excellent response to corticosteroid and immunosuppressive therapy.
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